At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Speakers: María Jose Serrano, PhD, Hospital Universitario Virgen de las Nieves, and Rocio Ramos-Medina, PhD, Hospital General Universitario Gregorio Marañón
About These Presentations:
This special workshop is from the ISLB 2020 Virtual Congress. Dr. María Jose Serrano discusses using IsoFlux for the detection and characterization of CTCs in early stage cancer. Dr. Rocio Ramos-Medina discusses the impact of IsoFlux CTC isolation in clinical practice.